Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added recruitment status note 'No longer looking for participants' and new navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with an updated Revision: v3.6.0. Replaced the heading 'Intervention / Treatment' with 'Intervention/Treatment' and removed the older 'Revision: v3.5.5' tag.
    Difference
    0.4%
    Check dated 2026-06-13T17:46:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This indicates a new version of the document.
    Difference
    0.0%
    Check dated 2026-06-06T14:03:21.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page, indicating a newer platform revision tag. This change does not modify study details, eligibility criteria, or results on the page.
    Difference
    0.0%
    Check dated 2026-05-15T23:56:07.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page’s footer release/revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical trial study details.
    Difference
    0.0%
    Check dated 2026-04-24T16:46:03.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:59:07.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a new Resources entry: Cutaneous neuroendocrine carcinoma with Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-03T05:51:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.